Covered recipient · General Payments record
LAYNE A HERMANSEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,991.47
- Reported across 84 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $758.97 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $269.49 | 11 |
| Amgen Inc. | $198.74 | 6 |
| Phathom Pharmaceuticals, Inc. | $74.17 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $67.97 | 1 |
| Acerta Pharma LLC | $51.76 | 2 |
| UCB, Inc. | $28.79 | 1 |
| Inspire Medical Systems, Inc. | $23.49 | 1 |
| PFIZER INC. | $23.07 | 1 |
| Novo Nordisk AS | $21.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.49 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909200 | CMS |
| ABBVIE INC. | $20.76 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909202 | CMS |
| ABBVIE INC. | $26.05 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909204 | CMS |
| ABBVIE INC. | $24.37 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909206 | CMS |
| ABBVIE INC. | $29.19 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909208 | CMS |
| ABBVIE INC. | $22.94 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909210 | CMS |
| ABBVIE INC. | $27.54 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909212 | CMS |
| ABBVIE INC. | $7.20 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909214 | CMS |
| ABBVIE INC. | $24.57 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909216 | CMS |
| ABBVIE INC. | $22.09 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909218 | CMS |
| ABBVIE INC. | $54.29 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103909220 | CMS |
| Amgen Inc. | $27.83 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117276086 | CMS |
| Amgen Inc. | $121.84 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111598320 | CMS |
| Amgen Inc. | $22.41 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117276078 | CMS |
| Amgen Inc. | $9.40 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117276080 | CMS |
| Amgen Inc. | $14.63 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117276082 | CMS |
| Amgen Inc. | $2.63 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117276084 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.47 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104472254 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.29 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105277322 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $67.97 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146761951 | CMS |
| Inspire Medical Systems, Inc. | $23.49 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148059863 | CMS |
| Novo Nordisk Inc | $21.49 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097613937 | CMS |
| PFIZER INC. | $23.07 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131223460 | CMS |
| Phathom Pharmaceuticals, Inc. | $74.17 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151071742 | CMS |
| UCB, Inc. | $28.79 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143094593 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.